Riskpilot← Back to searchSign inGet full accessVästerhaninge Veterinärklinik AB
ABActiveOrg 5590882592ÅbyplanVeterinary activities · NACE 7500Est. 20164 employees
Revenue 2024
SEK 6,4M
+6% vs 2023
EBITDA margin
9.9%
-16% vs 2023
Equity ratio
16.7%
Financial strength
Net profit 2024
SEK 381K
+6% vs 2023
| Revenue | SEK 6,4M | +6% |
| EBITDA | SEK 639K | -16% |
| Net profit | SEK 381K | +6% |
| Total assets | SEK 2,1M | +85% |
| Equity | SEK 344K | +1027% |
| Employees | 4 | — |
Legal name
Västerhaninge Veterinärklinik AB
Org number
5590882592
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
1 december 2016
Share capital
SEK 50 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva veterinärvård, rehabilitering och försäljning av tillbehör i anslutning därtill samt därmed förenlig verksamhet.
Address
Åbyplan
Email
christine@v-hvetklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 293 | 5 279 | 5 560 | 6 069 | 6 425 |
| Staff expenses | — | — | — | −1 246 | — |
| EBITDA | −432 | 329 | 360 | 758 | 639 |
| Depreciation & amort. | −19 | −61 | −39 | −19 | −0 |
| EBIT | −451 | 268 | 321 | 739 | 639 |
| Net financials | −194 | −206 | −365 | −380 | −258 |
| Profit before tax | −645 | 62 | −45 | 359 | 381 |
| Tax | −0 | −0 | −0 | — | −0 |
| Net profit | −645 | 62 | −45 | 359 | 381 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 191 | 1 250 | 1 188 | 1 115 | 2 061 |
| Equity | −413 | −351 | −396 | −37 | 344 |
| Long-term debt | 260 | 281 | 389 | 0 | 534 |
| Short-term debt | 1 345 | 1 319 | 1 195 | 1 153 | 1 183 |
| Total debt | 1 605 | 1 600 | 1 584 | 1 153 | 1 717 |
EBITDA margin
9.9%
This company
15.8%
Market median
-37% vs market
20202024
Equity ratio
16.7%
This company
38.2%
Market median
-56% vs market
20202024
Return on equity
110.8%
This company
18.4%
Market median
+502% vs market
20202024
Net profit margin
5.9%
This company
8.1%
Market median
-27% vs market
20202024
Asset turnover
3.12×
This company
1.12×
Market median
+179% vs market
20202024
Debt / equity
4.99×
This company
0.62×
Market median
-705% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TE | Audit | 2024 |
| Former (1) | ||
FF | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Västerhaninge Veterinärklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Folke Fredrik Dellström | Audit | 0 companies |
| Tobias Eduard Berglund | Audit | 0 companies |
| Enio Chiacchiaretta | Deputy Board Member | 0 companies |
| Christine Adriana A Chiacchiaretta | Board of Directors | 0 companies |